百奧家庭互動(2100.HK)9月已累漲80%!月內推兩款手遊大超預期
格隆匯9月25日丨9月以來持續發力的百奧家庭互動(2100.HK)今日繼續大漲,現報0.86港元,漲10.26%,暫成交1251萬港元,最新總市值24億港元。該股目前股價已創出2015年6月以來新高,9月份已累漲80%。

據悉,公司於9月先後推出《食物語》和《奧拉星》兩款手遊,大超市場預期。《食物語》是百奧與騰訊遊戲合作的女性賽道首款產品,而《奧拉星》是在百奧原頁遊基礎上進行研發的一款產品。此外,打磨多年的《造物法則二》將於今年11月份推出,這款手遊今年7月份已經由Google Play在北美等23個國家上線,目前反響良好。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.